The novel findings in this study suggest that patients with type 2 diabetes have a significantly reduced risk for short-term mortality after hospitalization for aortic aneurysm compared with population-based control subjects.
Eating speed can affect changes in obesity, body mass index, and waist circumference in patients with type 2 diabetes.
A recent study examined mortality trends in adults with diabetes and assessed albumin-to-creatinine ratios and estimated glomerular filtration rates.
Risk of developing type 2 diabetes is associated with subtle elevations of glucose and lipids more than 20 years before diagnosis.
Diabetes care can be improved with enhanced communication between providers and patients and improved communication between members of the primary care team.
This is the first study to have validated a metformin dose adjustment as a function of the estimated glomerular filtration rate in patients with type 2 diabetes and chronic kidney disease.
The bidirectional relationship between severe hypoglycemic events and cardiovascular outcomes suggests that there may be a common "frail" type 2 diabetes phenotype of patients who are susceptible to both of these events.
Higher rates of operative delivery and falling gestational age at delivery suggest that this is either reflected by, or despite, increasing obstetric intervention.
Two recently-approved diabetes treatments, a semaglutide injection and an insuline aspart injection, are now available in pharmacies across the United States.
Patients with type 2 diabetes who received once-weekly semaglutide had statistically greater reductions in HbA1c and body weight compared with those treated with dulaglutide.
Endocrinology Advisor Articles
- Effect of Sugar-Sweetened Beverages on Obesity Development
- Denosumab May Increase BMD in Women With Primary Hyperparathyroidism
- Risk Factors for Diabetes May Be Identified 20 Years Before Diagnosis
- T2D May Play a Protective Role Against Developing Aortic Diseases
- Diabetes Mortality Trends in Adults With Low eGFR, No Albuminuria
- Metformin Safe in T2D With Moderate to Severe Chronic Kidney Disease
- SGLT2 Inhibitors Show High Cardiovascular- and Renal-Protective Effects in T2D
- Type 2 Diabetes Insulin Initiation: Predictors Identified
- Two New Diabetes Medications Now Available
- Managing Acute Pain in Patients With Severe Obesity
- Effect of Biologic DMARDs on Spinal Fracture Risk in Ankylosing Spondylitis
- Metformin and PCOS: Improving Menstrual Cycle and Hormone Profiles
- Case: A 67-Year-Old Man With Shortness of Breath After Wildfires
- Sudden Sensorineural Hearing Loss Recovery Lower With Metabolic Syndrome
- Weight Regain More Likely With Perfluoroalkyl Substances